Your browser doesn't support javascript.
loading
Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review.
Alderson, Mark R; Arkwright, Peter D; Bai, Xilian; Black, Steve; Borrow, Ray; Caugant, Dominique A; Dinleyici, Ener Cagri; Harrison, Lee H; Lucidarme, Jay; McNamara, Lucy A; Meiring, Susan; Sáfadi, Marco A P; Shao, Zhujun; Stephens, David S; Taha, Muhamed-Kheir; Vazquez, Julio; Zhu, Bingqing; Collaborators, Gmi.
Afiliação
  • Alderson MR; PATH, Seattle, WA, USA.
  • Arkwright PD; Lydia Becker Institute of Immunology & Inflammation, University of Manchester, Manchester, UK.
  • Bai X; Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, UK.
  • Black S; Center for Global Health, Cincinnati Children's Hospital, Cincinnati, OH, USA.
  • Borrow R; Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, UK. Electronic address: ray.borrow@phe.gov.uk.
  • Caugant DA; Division for Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
  • Dinleyici EC; Eskisehir Osmangazi University Faculty of Medicine, Department of Pediatrics, Eskisehir, Turkey.
  • Harrison LH; Center for Genomic Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA.
  • Lucidarme J; Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, UK.
  • McNamara LA; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC, USA.
  • Meiring S; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
  • Sáfadi MAP; Department of Pediatrics, Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil.
  • Shao Z; State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, Peop
  • Stephens DS; Robert W Woodruff Health Sciences Center, Emory University, Atlanta, Georgia, USA.
  • Taha MK; Institut Pasteur, National Reference Centre for Meningococci and Haemophilus influenzae, Paris, France.
  • Vazquez J; National Centre of Microbiology, Institute of Health Carlos III, Madrid, Spain.
  • Zhu B; State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, Peop
  • Collaborators G; GMI Collaborators: Sotharith Bory, Suzana Bukovski, Josefina Carlos, Chien-Shun Chiou, Davor Culic, Trang Dai, Snezana Delic, Medeia Eloshvili, Tímea Erdos, Jelena Galajeva, Prakash Ghimire, Linda Glennie, Setyo Handryastuti, Jung Yeon Heo, Amy Jennison, Hajime Kamiya, Pavla Krízová,Tonnii Sia Loong
J Infect ; 84(3): 289-296, 2022 03.
Article em En | MEDLINE | ID: mdl-34838594
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Meningocócicas / COVID-19 / Infecções Meningocócicas / Neisseria meningitidis Tipo de estudo: Clinical_trials / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Meningocócicas / COVID-19 / Infecções Meningocócicas / Neisseria meningitidis Tipo de estudo: Clinical_trials / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos